Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Merck & Co. Inc.

BioPhotonics
Jan 2007
Merck & Co. Inc. of Whitehouse Station, N.J., has entered into a research collaboration with Neuroptix Corp. of Acton, Mass. Under terms of the agreement, Merck will receive a license to purchase and use its partner’s laser eye scanning devices -- which have detected Alzheimer’s-related amyloid protein aggregates on mouse eye lenses -- in preclinical studies and during trial drug monitoring. In exchange, Neuroptix will receive an upfront payment, annual technology access fees, and continuing payments on instruments and services, and on the diagnostic agents used with the scanner.

BiophotonicsMerck & Co. Inc.News & Featuresscanning devices

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.